← Back to Clinical Trials
Recruiting NCT06420206

NCT06420206 Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06420206
Status Recruiting
Phase
Sponsor M.D. Anderson Cancer Center
Condition Lung Cancer
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2024-05-14
Primary Completion 2027-02-02

Trial Parameters

Condition Lung Cancer
Sponsor M.D. Anderson Cancer Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-05-14
Completion 2027-02-02
Interventions
Standard of Care (Acute Cancer Care Center)Standard of Care (Goals of Care)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To improve quality of life for participants with advanced cancer, support their families, and lower overall cost of care.

Eligibility Criteria

Inclusion Criteria: 1. Participant is at least 18 years old presenting to the triage area of the MDACC ACCC for treatment 2. Participant has advanced lung or GI cancer. Advanced cancer patient defined as: locally recurrent or metastatic for which there is no curative treatment available. 3. Participant screens positive for at least 2 of 3 triple threat conditions (dyspnea, altered mental status, or poor performance status) 4. Participant has the ability to speak and write in English 5. Participant has the ability to provide consent OR is accompanied by a LAR able to provide consent Exclusion Criteria: 1. Participant is already enrolled in hospice 2. Participant is comatose 3. Participant has severe intellectual disability 4. Participant has a history of dementia documented in the medical records 5. Participant has baseline communication barriers such as aphasia or deafness 6. Participant is new to MDACC, without established oncology care at our institution at time of ACCC arrival 7. Pa

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology